Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115539 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von André Balsa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Portuguese Foundation for Science and Technology, RELAX-2-PAH.
Abstract (Originalsprache)
Pulmonary hypertension (PH) is a progressive condition that affects the pulmonary vessels, but its main prognostic factor is the right ventricle (RV) function. Many mice/rat models are used for research in PAH, but results fail to translate to clinical trials. This study reviews studies that test interventions on pulmonary artery banding (PAB), a model of isolated RV disfunction, and PH models. Multiple tested drugs both improved pulmonary vascular hemodynamics in PH models and improved RV structure and function in PAB animals. PH models and PAB animals frequently exhibited similar results (73.1% concordance). Macitentan, sildenafil, and tadalafil improved most tested pathophysiological parameters in PH models, but almost none in PAB animals. Results are frequently not consistent with other studies, possibly due to the methodology, which greatly varied. Some research groups start treating the animals immediately, and others wait up to 4 weeks from model induction. Treatment duration and choice of anaesthetic are other important differences. This review shows that many drugs currently under research for PAH have a cardioprotective effect on animals that may translate to humans. However, a uniformization of methods may increase comparability between studies and, thus, improve translation to clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
- Department of Pharmacology and Toxicology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
- CIBER of Respiratory Diseases (CIBERES), 28029 Madrid, Spain.
- Faculty of Nutrition and Food Sciences, University of Porto, 4150-180 Porto, Portugal.
ORCID-Profile: Rui Adão, Carmen Brás-Silva
Förderung
- Fundação para a Ciência e Tecnologia
- Portuguese Foundation for Science and Technology
- RELAX-2-PAH
- IMPAcT
- European Union’s Horizon 2020 research and innovation programme
Zitieren
APA
Balsa, A., Adão, R., & Brás-Silva, C. (2023). Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115539
Vancouver
Balsa A, Adão R, Brás-Silva C. Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115539
BibTeX
@article{Balsa2023,
author = {Balsa, André and Adão, Rui and Brás-Silva, Carmen},
title = {Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115539}
}
EUVIMED